Pharming (PHAR) Operating Expenses (2020 - 2026)

Pharming (PHAR) has 7 years of Operating Expenses data on file, last reported at -$88.0 million in Q2 2026.

• Quarterly Operating Expenses changed 0.18% year-over-year to -$88.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$309.1 million (down 8.35% YoY) and the FY2025 annual result came in at $411.7 million, up 15.74% from the prior year.
• Operating Expenses fell to -$88.0 million in Q2 2026, from -$40.8 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of -$31.9 in Q2 2023 to a low of -$180.3 million in Q4 2025.
• A 5-year average of -$54.9 million and a median of -$37.2 million in 2024 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2023 — Operating Expenses surged 100.0% — and 2024, when it slumped 222021843.57%.
• Tracing PHAR's Operating Expenses over 5 years: stood at -$98.5 million in 2022, then soared by 100.0% to -$89.2 in 2023, then tumbled by 172418061.43% to -$153.8 million in 2024, then declined by 17.25% to -$180.3 million in 2025, then surged by 51.21% to -$88.0 million in 2026.
• The last three Operating Expenses figures came in at -$88.0 million (Q2 2026), -$40.8 million (Q1 2026), and -$180.3 million (Q4 2025), per Business Quant data.